Metraipolis › archive › dc_783e4c32cc83

Safety and pharmacokinetics of sulfasalazine and its metabolite sulfapyridine for treatment of preterm preeclampsia in Australia (SIP): an early phase,… — Europe PMC PMID:41675296

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41675296
DOI
10.1016/j.eclinm.2026.103779
License (as archived)
solo-consultazione
Archived
2026-11-06T03:58:00.945Z
SHA-256 of the archived text
ef51a4e98d3c1ab0b28bafc94f2529d9583d3f6e7a012265ce1eeb247c669809
Stable URL of this page
https://metraipolis.com/documento/dc_783e4c32cc83

How to cite

Safety and pharmacokinetics of sulfasalazine and its metabolite sulfapyridine for treatment of preterm preeclampsia in Australia (SIP): an early phase,… — Europe PMC PMID:41675296 — Europe PMC (en), https://europepmc.org/article/MED/41675296 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_783e4c32cc83 (Metraipolis archive dc_783e4c32cc83, sha256 ef51a4e98d3c1ab0b28bafc94f2529d9583d3f6e7a012265ce1eeb247c669809)
BibTeX
@misc{dc783e4c32cc83,
  title = {Safety and pharmacokinetics of sulfasalazine and its metabolite sulfapyridine for treatment of preterm preeclampsia in Australia (SIP): an early phase,… — Europe PMC PMID:41675296},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41675296},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_783e4c32cc83; sha256 ef51a4e98d3c1ab0b28bafc94f2529d9583d3f6e7a012265ce1eeb247c669809},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41675296. Agents can read the archived copy with the MCP tool read_document.